Your browser doesn't support javascript.
loading
An epigenomic approach to therapy for tamoxifen-resistant breast cancer.
Feng, Qin; Zhang, Zheng; Shea, Martin J; Creighton, Chad J; Coarfa, Cristian; Hilsenbeck, Susan G; Lanz, Rainer; He, Bin; Wang, Lei; Fu, Xiaoyong; Nardone, Agostina; Song, Yongcheng; Bradner, James; Mitsiades, Nicholas; Mitsiades, Constantine S; Osborne, C Kent; Schiff, Rachel; O'Malley, Bert W.
Afiliación
  • Feng Q; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Zhang Z; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Shea MJ; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • Creighton CJ; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • Coarfa C; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • Hilsenbeck SG; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • Lanz R; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
  • He B; 1] Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA [2] Department of Medicine-Hematology & Oncology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Wang L; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Fu X; 1] Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA [2] Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA [3] Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • Nardone A; 1] Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA [2] Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA [3] Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • Song Y; Department of Pharmacology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Bradner J; Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.
  • Mitsiades N; 1] Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA [2] Department of Medicine-Hematology & Oncology, Baylor College of Medicine, Houston, TX 77030, USA.
  • Mitsiades CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.
  • Osborne CK; 1] Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA [2] Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA [3] Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • Schiff R; 1] Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA [2] Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA [3] Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • O'Malley BW; 1] Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA [2] Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.
Cell Res ; 24(7): 809-19, 2014 Jul.
Article en En | MEDLINE | ID: mdl-24874954

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Represoras / Tamoxifeno / Neoplasias de la Mama / N-Metiltransferasa de Histona-Lisina / Resistencia a Antineoplásicos / Receptor alfa de Estrógeno Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cell Res Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Represoras / Tamoxifeno / Neoplasias de la Mama / N-Metiltransferasa de Histona-Lisina / Resistencia a Antineoplásicos / Receptor alfa de Estrógeno Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cell Res Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos